CHINA Biotech firm makes test kit for new virus variant

CHINA

Biotech firm makes test kit for new virus variant

China Daily

17:17, January 05, 2021

BGI Genomics, a Shenzhen-based biotech company, on Tuesday announced the successful development of a rapid detection kit for the new strain of the novel coronavirus, known as SARS-CoV-2 B.1.1.7, which was originally discovered in the UK.

(File photo: CFP)

For COVID-19 positive cases, the company pledged the test kit could further identify and diagnose the new strain's main mutation N501Y in one hour.

BGI stated that the test kit is still only in use for research purposes for now. So far, Guangdong, Shanghai and Hong Kong have found confirmed cases of the new variants on people returning from the UK.

The company is a major producer of test kits and labs for China and the world in the fight against the pandemic.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue